NEW YORK (360Dx) – T2 Biosystems reported after the close of the market on Thursday that its second quarter revenues skyrocketed fourfold year over year, beating the consensus Wall Street estimate.

For the three months ended June 30, 2018, the company posted revenues of $3.9 million, compared to $956,000 in the same period the year before. The analysts' average estimate was $2.9 million.